( June 26, 2025, 2:09 PM EDT) -- SAN FRANCISCO — Hims & Hers Health Inc., a telehealth company that touted a collaboration with Novo Nordisk Inc. that would allow it to sell compounded semaglutide products, was hit with a securities fraud class action on June 25 by a shareholder who alleges that the stock value plummeted when Novo Nordisk ended the partnership....